Position in IQV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$200,175
New position
Shares Held
1,036
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#833
of 1,077 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026TritonPoint Partners, LLC holds $26,038,366 across 6 Diagnostics & Research names. IQV ranks #6 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
63,242 | $12,046,336 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
19,423 | $9,737,915 | |
| 3 | LH |
Labcorp Holdings Inc.
|
10,433 | $2,921,240 | |
| 4 | A |
Agilent Technologies, Inc.
|
6,589 | $875,216 | |
| 5 | CSTL |
Castle Biosciences Inc
|
10,796 | $257,484 | |
| 6 | IQV |
Iqvia Holdings Inc.
This page
|
1,036 | $200,175 |
All Filings in IQV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $200,175 | 1,036 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||